Drug Profile
LE-SN38
Alternative Names: LE SN38; Liposome encapsulated SN38; SN-38 liposomalLatest Information Update: 21 Aug 2019
Price :
$50
*
At a glance
- Originator NeoPharm Inc
- Class Antineoplastics; Camptothecins
- Mechanism of Action DNA topoisomerase I inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Colorectal cancer
Most Recent Events
- 18 Oct 2016 Discontinued - Phase-II for Colorectal cancer (Second-line therapy or greater) in USA (IV)
- 19 Jul 2011 No development reported - Phase-II for Colorectal cancer in USA (IV)
- 13 May 2009 Suspended - Phase-II for Colorectal cancer in USA (IV)